by Oh Jooyean
Published 14 Oct.2020 14:51(KST)
[Asia Economy Reporter Oh Ju-yeon] Alteogen announced on the 14th that it has acquired a domestic patent for a new growth hormone receptor antagonist with strong binding affinity to the growth hormone receptor.
The company stated, "It can be used in the development of treatments for diseases caused by excessive secretion of growth hormone."